Cardiac dysrhythmias

This category covers several different disorders, all of which represent a disruption to normal sinus cardiac rhythm. The disruption may result in a disordered rhythm or rate.

...


Read more on Cardiac dysrhythmias

 

 

Latest news articles

Added 10 days ago Congress news

Urgent action needed as atrial fibrillation set to affect millions of over-65’s in the EU by 2060

Report from a paper published during World Heart Rhythm Week which is held between the 3rd and 9th of June this year.

Added 25 days ago Drug news

OPTION trial initiated to compare WATCHMAN FLX left atrial appendage closure platform to first-line oral anticoagulants

Boston Scientific Corporation has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX left atrial...

Added 26 days ago Drug news

Stereotaxis launches Stereotaxis Genesis RMN to advance robotic magnetic navigation technology

Stereotaxis the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, introduced Stereotaxis Genesis RMN, the next-generation...

Search all news articles for Cardiac dysrhythmias
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Load more

Guidelines

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Despite good progress in the management of patients with atrial fibrillation (AF), this arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity in the world.

Added 1 year ago

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

In light of the very recent consensus documents for the management of patients with VA released by the major international heart rhythm societies, the ESC Guidelines Committee decided to focus the content of this document on the prevention of SCD.

Added 3 years ago

2014 ESC/EACTS Guidelines on myocardial revascularization

In 2014, coronary artery bypass grafting (CABG) celebrates the 50th anniversary of the first procedures performed in 1964. Thirteen years later, the first percutaneous coronary intervention (PCI) was performed.

Added 4 years ago

Search all guidelines for Cardiac dysrhythmias
 

Journal articles

Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management.

Areas covered: We will briefly discuss the obesity paradox and its mechanisms regarding cardiac and hemodynamic function changes. In the first main part of this review, we will be discussing risk assessment studies...

Added 2 months ago

Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.

Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke (AIS) is contraindicated in patient taking either Factor Xa inhibitors or direct thrombin inhibitors.

Added 2 months ago

Reversal strategies in patients treated with direct oral anticoagulants.

The aim of this review is to summarize recent study data and recommendations on nonspecific and specific DOAC reversal strategies and to present the current evidence.

Added 2 months ago

Search all journal articles for Cardiac dysrhythmias
 

Clinical trials

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

The primary objective is to demonstrate reversal of the anticoagulant effect of dabigatran in patients treated with dabigatran etexilate who have uncontrolled or life-threatening bleeding requiring urgent intervention, and in patients treated...

Added 21 hours ago

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) (EMANATE)

Some people can develop an abnormal heart beat known as "Atrial fibrillation" or "AF" that puts them at risk of developing clots in the heart. Those clots can travel in the blood circulation to the brain and cause a...

Added 1 year ago

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

The primary purpose of this study is to evaluate the safety for 2 different rivaroxaban treatment strategies and one Vitamin K Antagonist (VKA) treatment strategy utilizing various combinations of dual antiplatelet therapy (DAPT)...

Added 1 year ago

Search all clinical trials for Cardiac dysrhythmias
 
Laura Quittenden

Laura Quittenden joined epgonline.org as Digital Marketing Executive in November 2017. Responsible for communications across social media and the website, Laura is quickly becoming an expert on the medical content calendar and is always on hand to remind the team that it is World

... Read more

What is AF or Atrial Fibrillation?

This week, from the 20th to the 26th November it is Global AF Awareness Week. Here we explore Atrial Fibrillation (also called AF or AFib), the most common heart rhythm disorder that can lead to stroke, blood clots, heart failure and other heart-related complications. Over 1 million people have been diagnosed with AF in the UK alone.  

CME

Starting patients on anticoagulants in secondary care: how to do it

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Starting patients on oral anticoagulants in primary care: how to do it

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Maintaining patients on oral anticoagulants: how to do it

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Cardiac dysrhythmias